Topiramate Capsule, Extended Release
Product Images NDC 72603-121

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 72603-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A cumulative rate line graph depicting time to first seizure over 500 days for two dosage groups of topiramate: 50 mg/day and 400 mg/day. The y-axis represents cumulative rates while the x-axis represents time in days. The graph compares seizure occurrence between the two dosages in study populations of 234 and 236 patients respectively.*

FDA Label Image

Figure2 (Figure2)

A bar chart comparing the proportion of patients by percentage reduction in seizure frequency from baseline between placebo and Topiramate 200 mg/day groups. The x-axis shows categories of seizure reduction percentages, and the y-axis shows the proportion of patients in percentage.*

FDA Label Image

Figure3 (Figure3)

A bar chart showing the change from baseline to double-blind phase in average monthly migraine period rate (±SE) for topiramate at placebo, 50 mg/day, 100 mg/day, and 200 mg/day doses across two studies. The chart includes sample sizes for each group and indicates statistical significance levels with asterisks for different doses.*

FDA Label Image

Lbl100mg30s (Lbl100mg30s)

Label for Topiramate Extended-Release Capsules 100 mg, 30-count bottle. The label includes the NDC 72603-122-01 and states the product is for once-daily dosing. It is manufactured by Glenmark Pharmaceuticals Limited, India for NorthStar Rx LLC. The label has a blue and white design with storage instructions and a barcode.*

FDA Label Image

Lbl150mg30s (Lbl150mg30s)

Label for Topiramate Extended-Release Capsules, 150 mg, with a 30-capsule count. The label includes dosage strength in a green box, manufacturer details (Glenmark Pharmaceuticals Limited, India), and distributor (Northstar Rx LLC, Memphis, TN). Displays NDC 72603-123-01, storage instructions, and a barcode.*

FDA Label Image

Lbl200mg30s (Lbl200mg30s)

Topiramate Extended-Release Capsules 200 mg label showing a 30-capsule package. The label includes dosage information, storage instructions, manufacturer details (Glenmark Pharmaceuticals Limited, India), and distributor (Northstar Rx LLC). It highlights that each capsule contains 200 mg of topiramate and is intended for once-daily oral dosing.*

FDA Label Image

Lbl25mg30s (Lbl25mg30s)

Topiramate Extended-Release Capsules 25 mg bottle label by NorthStar Rx LLC, showing a 30-capsule count. The label includes storage instructions, manufacturer details (Glenmark Pharmaceuticals Limited, India), and a barcode. The label emphasizes once-daily dosing and is marked Rx only.*

FDA Label Image

Lbl50mg30s (Lbl50mg30s)

Drug information panel for Topiramate Extended-Release Capsules 50 mg, including dosage instructions, storage conditions, manufacturer details (Glenmark Pharmaceuticals Limited, India), and a barcode. The panel also notes this package contains 30 capsules and includes safety instructions.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of topiramate, the active ingredient in TOPIRAMATE oral extended-release capsules by NorthStar RxLLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.